IN2014DN10127A - - Google Patents

Info

Publication number
IN2014DN10127A
IN2014DN10127A IN10127DEN2014A IN2014DN10127A IN 2014DN10127 A IN2014DN10127 A IN 2014DN10127A IN 10127DEN2014 A IN10127DEN2014 A IN 10127DEN2014A IN 2014DN10127 A IN2014DN10127 A IN 2014DN10127A
Authority
IN
India
Prior art keywords
sample
animal
valvular disease
chronic valvular
amount
Prior art date
Application number
Other languages
English (en)
Inventor
Qinghong Li
Dorothy P Laflamme
Steven S Hannah
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2014DN10127A publication Critical patent/IN2014DN10127A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5758
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/326Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/16Phosphorus containing
    • Y10T436/163333Organic [e.g., chemical warfare agents, insecticides, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666Carboxylic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
IN10127DEN2014 2012-06-05 2013-06-04 IN2014DN10127A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261655704P 2012-06-05 2012-06-05
PCT/US2013/044008 WO2013184628A1 (en) 2012-06-05 2013-06-04 Methods for diagnosing chronic valvular disease

Publications (1)

Publication Number Publication Date
IN2014DN10127A true IN2014DN10127A (enExample) 2015-08-21

Family

ID=48626663

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10127DEN2014 IN2014DN10127A (enExample) 2012-06-05 2013-06-04

Country Status (12)

Country Link
US (1) US20150153353A1 (enExample)
EP (1) EP2856170B1 (enExample)
JP (1) JP6174689B2 (enExample)
CN (1) CN104364658B (enExample)
AU (1) AU2013271879B2 (enExample)
BR (1) BR112014030243B1 (enExample)
CA (1) CA2875331C (enExample)
ES (1) ES2687979T3 (enExample)
IN (1) IN2014DN10127A (enExample)
MX (1) MX358561B (enExample)
RU (1) RU2667634C2 (enExample)
WO (1) WO2013184628A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184932B2 (en) * 2015-12-07 2019-01-22 Zora Biosciences Oy Use of ceramides and LPLs in diagnosing CVD

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
EP2164977B1 (en) * 2007-07-17 2013-10-30 Metabolon, Inc. Biomarkers for pre-diabetes and methods using the same
CA2705325C (en) * 2007-11-09 2016-11-01 The Board Of Regents Of The University Of Texas System Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
EP2283358B1 (en) * 2008-04-29 2015-04-22 Immunexcite, Inc. Immunomodulating compositions and methods of use thereof
PL2271933T3 (pl) * 2008-05-07 2013-05-31 Univ Strathclyde System i sposób charakteryzowania komórek
RU2011135768A (ru) * 2009-01-29 2013-03-10 Эбботт Лэборетриз Белки, связывающие il-1
MX2013000917A (es) * 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.

Also Published As

Publication number Publication date
ES2687979T3 (es) 2018-10-30
RU2014153109A (ru) 2016-08-10
JP6174689B2 (ja) 2017-08-02
MX2014014791A (es) 2015-02-24
CN104364658B (zh) 2017-06-30
AU2013271879B2 (en) 2019-03-28
RU2667634C2 (ru) 2018-09-21
CA2875331A1 (en) 2013-12-12
WO2013184628A1 (en) 2013-12-12
AU2013271879A1 (en) 2014-12-18
CA2875331C (en) 2022-11-29
BR112014030243B1 (pt) 2022-07-05
US20150153353A1 (en) 2015-06-04
EP2856170B1 (en) 2018-07-25
BR112014030243A2 (pt) 2017-06-27
MX358561B (es) 2018-08-24
JP2015524066A (ja) 2015-08-20
CN104364658A (zh) 2015-02-18
EP2856170A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
Murphy et al. A review of behavioural methods to study emotion and mood in pigs, Sus scrofa
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
MX2021012301A (es) Anticuerpos madurados por afinidad y humanizados para fcrh5 y metodos para su uso.
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
MX2017013383A (es) Prediccion de respuesta a alvocidib mediante perfilado mitocondrial.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
EP3602218A4 (en) Predictive integrity analysis
EP2971141A4 (en) SYSTEMS AND METHODS FOR BIOLOGICAL ANALYSIS
EP2967391A4 (en) SYSTEMS AND METHOD FOR THE DIAGNOSIS OF CORONARY MICROVASCULAR DISEASES
MX365061B (es) Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
EP3411720A4 (en) DIAGNOSIS AND PROGNOSIS PROCEDURE FOR HEART CIRCULAR DISEASES AND EVENTS
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX375421B (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
EP2994721A4 (en) Quantitative analysis of signal related measurements for trend and pattern recognition
IL283467A (en) Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
LT2970345T (lt) 18f-žymėti pozitronų emisijos tomografijos (pet) vizualizacijos agentai, nukreipti į prostatos atžvilgiu specifinius membranos antigenus (psma)
WO2015034886A3 (en) Wellness panel for companion animals
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
SG10201806729VA (en) Novel assay to detect human periostin
KR101942197B9 (ko) 세균 메타게놈 분석을 통한 전립선질환 진단 방법
IN2013CH05587A (enExample)
MX2016007148A (es) Metodos de ensayo de beta-glucano.
WO2014169011A3 (en) Methods for treating immune diseases
EP2984487A4 (en) METHOD FOR EVALUATING BIOLOGICAL SAMPLES USING CYTOLOGY AND IMMUNOLOGY
MX2018000189A (es) Metodo para el diagnostico de la enfermedad de farber.